Obesity Could Cause 40% of Hormone-Positive Breast Cancers in Older Women
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
WEDNESDAY, Oct. 16, 2024 -- Obesity is a more powerful driver of breast cancer than previously thought, a new study suggests.
About 40% of hormone-positive breast cancers in postmenopausal women might be linked to excess body fat, researchers reported Oct. 15 in the Journal of Epidemiology & Community Health.
That’s significantly more than previous estimates that linked excess weight to 1 in 10 breast cancer cases, based on measures of women’s body-mass index (BMI), researchers said.
The real-world impact of obesity on breast cancer risk likely has been underestimated because BMI isn’t a very accurate measure of body fat, the researchers argued.
“The findings of this study highlight the importance of considering more accurate measures of body fat than BMI to estimate the cancer burden attributable to obesity in postmenopausal breast cancer,” concluded the research team led by Veronica Davila-Batista, an associate professor of epidemiology with the University of Las Palmas de Gran Canaria in Spain.
For this study, researchers compared BMI with a different measure of body fat called the CUN-BAE, an equation which accounts for gender and age in BMI measurements.
The two measures were used to weigh 1,022 older Spanish women with breast cancer and another 1,143 matched women who didn’t have cancer.
About 23% of breast cancer cases were linked to excess body weight as measured by BMI, researchers found.
However, about 38% of breast cancers were linked to excess fat as measured by the CUN-BAE, results show.
These differences were strongest for hormone-positive cancers, which are those driven by female hormones like estrogen, researchers said.
Twice as much risk for hormone-positive breast cancers could be linked to excess fat when using the CUN-BAE equation -- 42%, compared with 20% when using BMI.
“The results of our study indicate that excess body fat is a significant risk factor for hormone receptor-positive breast cancer in postmenopausal women,” the researchers wrote in a journal news release.
Body fat can increase estrogen levels in women because fat tissue secretes the female hormone, according to the Cleveland Clinic.
“Our findings suggest that the population impact could be underestimated when using traditional BMI estimates, and that more accurate measures of body fat, such as CUN-BAE, should be considered when estimating the cancer burden attributable to obesity in postmenopausal breast cancer,” the research team concluded.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-17 00:00
Read more
- July 2019 to June 2023 Saw Increase in OD Deaths With Ketamine Detected
- Quitting Smoking After Cancer Diagnosis Boosts Survival by Up to 26%
- President-Elect Trump to Pick Mehmet Oz to Head CMS
- UCB Receives U.S. FDA Approval for Bimzelx (bimekizumab-bkzx) as the First IL-17A and IL-17F Inhibitor for Adults with Moderate to Severe Hidradenitis Suppurativa
- How AI Might Help Men Fighting Prostate Cancer
- Two-Fifths of Americans Say They Experience the 'Winter Blues'
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions